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Macrocycles constitute superior ligands for targets that have flat binding sites but often require long
synthetic routes, emphasizing the need for property prediction prior to synthesis. We have investigated
the scope and limitations of machine learning classification models and of regression models for pre-
dicting the cell permeability of a set of de novo-designed, drug-like macrocycles. 2D-Based classification
models, which are fast to calculate, discriminated between macrocycles that had low-medium and high
permeability and may be used as virtual filters in early drug discovery projects. Importantly, stereo- and
regioisomer were correctly classified. QSPR studies of two small sets of comparator drugs suggested that
use of 3D descriptors, calculated from biologically relevant conformations, would allow development of
more precise regression models for late phase drug projects. However, a 3D permeability model could
only be developed for a rigid series of macrocycles. Comparison of NMR based conformational analysis
with in silico conformational sampling indicated that this shortcoming originates from the inability of
the molecular mechanics force field to identify the relevant conformations for flexible macrocycles. We
speculate that a Kier flexibility index of 10 constitutes a current upper limit for reasonably accurate 3D
prediction of macrocycle cell permeability.
© 2020 The Authors. Published by Elsevier Inc. on behalf of the American Pharmacists Association®. This
is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).Introduction
Macrocycles are attracting major interest in efforts to "drug"
targets which cannot bemodulated by small molecules that comply
with the Lipinski's rule of 5 (Ro5).1,2 A comprehensive investigation
of drugs and clinical candidates residing in beyond rule of 5 (bRo5)
space highlighted that the unique ability of macrocycles to adopt
disk- and sphere-like shapes makes them ideal for binding to tar-
gets that have flat and groove-shaped binding sites,2 i.e. targets that
are difficult to modulate with Ro5 compliant compounds. However,
macrocyclic drugs often require long synthetic routes,3 which
emphasizes the importance of developing methods for prediction
of properties such as cell permeability before initiating synthesis.
Passive cell permeability is a complex process which involves
desolvation when the drug leaves the extracellular aqueous envi-
ronment, followed by interactions with the negatively chargedn), jan.kihlberg@kemi.uu.se
Inc. on behalf of the American Phaphospholipid head groups before it enters the hydrophobic mem-
brane interior.4 Then, this sequence of events is reversed as the
drug enters the cytosol. Each of these steps is affected to different
extents by the drug's molecular properties.4 For instance, the po-
larity of the compound which can be described by its 3D polar
surface area (PSA) is a major determinant of the kinetics of the
desolvation step. The size of the compound, approximated by the
radius of gyration (Rgyr), governs the rate of diffusion across the
membrane, while the lipophilicity (cLogP or cLogD) is of major
importance for the thermodynamics of the permeation process.
Quantitative structure-permeability relationship (QSPR) methods
arewidely used tomodel permeability in drug discovery. They rely on
statistical relationships derived from experimental permeability data
and physicochemical descriptors, such as the PSA, Rgyr and cLogP/D,
calculated for a training set of compounds.5 An alternate approach is
to develop models that are more directly based on the physics of the
underlying processes.6e9 Physics-based models have provided an in-
depth understanding of how small sets of macrocyclic hexa-, hepta-
and decapeptides composed of neutral and lipophilic residues may
cross cell membranes.8e13 These models have been developed using
substantial computational and experimental resources and are basedrmacists Association®. This is an open access article under the CC BY license (http://
Fig. 1. Chemical structures of (a) members of each of the seven series that make up the
majority of the DOS macrocycle set, (b) selected members of the linear drug set for
which the number of rotatable bonds increases from 1 to 15, and (c) a member of each
of the four classes of drugs in the training set of the bRo5 drug set.
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permeating species. Alternatively, ensemble-based solvent accessible
surface area13 and ensemble-based 3D polar surface area14 have been
found to be good predictors of the permeability of cyclic peptides and
semipeptidic macrocycles, respectively.
Previously, we have investigated a set of more than 200 non-
peptidic, de novo-designed macrocycles inspired by natural prod-
ucts to obtain knowledge about the cell permeability of drug-like
macrocycles.15 QSPR models of good predictive power were ob-
tained, as well as information on how substructural features
ranging from the numbers of hydrogen bond donors and acceptors
to different functional groups and substituents affected perme-
ability. However, the cell permeabilities of the members of stereo-
and regioisomeric series, which sometimes differed by an order of
magnitude, could not be predicted by the QSPR models which were
based on 2D descriptors. Instead, manual scoring of the overall
polarity, the degree of intramolecular hydrogen bonding and gen-
eral steric shielding of polar groups in the ensembles of low-energy
conformations of the isomers allowed a qualitative ranking of their
permeability. However, such manual studies are time consuming
and may not always be applicable for other regio- and stereoiso-
meric series. Consequently, they are less suitable for incorporation
in an industrialized drug discovery process than QSPR models.
Herein we have first investigated the ability of methods based
on machine learning to provide a rapid and accurate classification
of macrocycles as either having low-medium or high permeability
across Caco-2 cell monolayers. Suchmethods could be of significant
value for rapid decision making in design of macrocycles in the
early phases of drug discovery projects. Then we have investigated
the scope and limitations in prediction of cell permeability for
stereo- and regioisomers using 3D descriptors calculated for con-
formers obtained by sampling using the distance-geometry based
software OMEGA. Such an approach (3D-QSPR) would be of use in
lead optimization of series of macrocycles; in a previous work16 we
showed that models based on the 3D PSA of experimentally
determined conformers performed better than those based on the
2D descriptor TPSA. We based the current investigation on a subset
of the 200 non-peptidic, de novo-designed macrocycles that only
displayed passive cell permeability. Two sets of drugs were used as
comparator sets, one being a set of non-macrocyclic (linear) drugs,
most of which comply with the Ro5, while the other one consists of
both macrocycles and non-macrocycles residing in bRo5 space.
Materials and Methods
General Description of Compound Sets
We based this study on three sets of compounds, i) a set of de
novo-designed macrocycles inspired by natural products that has
been prepared by diversity oriented synthesis (the DOS macrocycle
set),15 ii) a set of approved, non-macrocyclic drugs (the linear drug
set)17 and iii) a set of approved drugs all of which reside in the
beyond rule of 5 chemical space (the bRo5 drug set).16
The DOS macrocycle set consists of 70 of the just over 200 mac-
rocycles for which the permeability across Caco-2 cell monolayers
was determined earlier under consistent conditions.15 As discussed in
the Introduction, models for the cell permeability of the full set of
>200 macrocycles have been reported, as well as in-depth studies of
a few of its series.15 Herein we selected only those macrocycles that
did not display any residual efflux (efflux ratio <2) in the presence of
a cocktail of inhibitors of the three major efflux transporters, i.e. a set
of macrocycles associated with passive cell permeability. Their
permeability was fairly evenly distributed over close to two orders of
magnitude, (Supplementary Fig. 1, Supplementary Table 1). The
majority, i.e. 52 of the 70macrocycles, can be grouped in seven serieswith compounds in each series differing only in their stereo- and
regiochemistry (Fig. 1a, series A-G; Supplementary Table 1). The
remaining 18 macrocycles are singletons (called the “Unique” series
(U), Supplementary Table 1) and display large structural variation.
The linear drug set includes 79 non-macrocyclic compounds
obtained from a previous study (Fig. 1b).17 From the original dataset
the following compounds were excluded: adefovir, acarbose and
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it is involved in active transport mechanisms,18,19 and azithromycin
and erythromycin since they are macrocycles. Caco-2 cell perme-
ability was determined under consistent conditions and the data is
distributed over close to three orders of magnitude (Supplementary
Fig. 1, Supplementary Table 2).16 The final dataset was split in two
subsets: non-flexible (n ¼ 49, called DS1) and flexible (n ¼ 30,
named DS2) according to the number of rotatable bonds (NRotB <6
for DS1,6 for DS2). Herein, it was used as a comparator compound
set to investigate if the impact of flexibility on modelling of cell
permeability of non-macrocyclic drugs is like that of macrocycles.
The bRo5 drug set includes 18 macrocyclic and non-macrocyclic
drugs in bRo5 space that were extensively investigated in a previ-
ous study (Fig. 1c, Supplementary Table 3).16 The efflux inhibited
Caco-2 cell permeability correlated strongly (r2 ¼ 0.90) with the
minimum solvent-accessible 3D polar surface areas (Min SA 3D
PSA) calculated from the crystal structure conformations of the ten
drugs in the training set of the bRo5 drug set. In addition, the
correlation between the permeability and Min SA 3D PSA of the
drugs in the training set predicted the permeabilities of the eight
drugs in the test set well (RMSE¼ 0.71). We used this as a reference
set to compare models of cell permeability based on experimental
knowledge of the compounds’ 3D conformations to models ob-
tained using conformational sampling.
Overall the DOS macrocycle set is the main compound set
investigated in this paper, the linear drug set is a comparator set of
non-macrocyclic approved drugs, most of which comply with the
Ro5, while the bRo5 comparator set consists of both macrocycles
and non-macrocyclic drugs.
Characterization of the three compound sets using the four
descriptors of Lipinski's rule of 520 (molecular weight, MW; the
number hydrogen bond acceptors and donors, HBA and HBD; and
the calculated lipophilicity, cLogP) and the descriptors of Veber's
rule21 (the topological polar surface area, TPSA, and the number of
rotatable bonds, NRotB) reveals differences and similarities be-
tween the three sets (Fig. 2). The linear drug set has the lowest MW
distribution, while the DOSmacrocycles and the bRo5 drug set have
increasingly higher MW distributions (Fig. 2a). The HBA and TPSA
distributions for the three compound sets reflects their MW dis-
tributions, i.e. compounds having higher MWs had higher numbers
of HBAs and greater values for TPSA (Fig. 2c and e). Apart for some
compounds in the bRo5 drug set most compounds in the three sets
had values below the upper cut-offs of the Ro5 and Veber's rule
(HBA 10 and TPSA <140). With very few exceptions values for
cLogP and HBD fall below their upper Ro5 cut-offs (5) for the
three compounds sets (Fig. 2b and d). However, the bRo5 drug set
has these two descriptors shifted towards somewhat higher values,
while the DOS macrocycle set has fewer HBDs than the other two
sets. NRotB falls below or at 10 (the upper limit in Veber's rules) for
most compounds in the three sets, but with the DOSmacrocycle set
and the bRo5 drug sets having compounds just outside or quite far
outside this upper limit, respectively (Fig. 2f).
3D Structures and Conformational Sampling
The Simplified Molecular-Input Line-Entry System (SMILES)
codes of all the compounds were obtained and converted into 3D
structure using CORINA (version 3.2) from Molecular Networks
GmbH.22,23 Special care was taken while converting the SMILES to
the 3D structures to make sure that the stereochemistry for all
compounds was correctly annotated according to the original
source.15 Uncharged (i.e. protonated acids and deprotonated bases)
and charged states (at pH 7.4) were generated for the compounds
using the Wash tool from MOE software (Molecular Operating
Environment, version 2015.10).24 Both uncharged and chargedstructures were submitted to conformational sampling using the
OMEGA tool fromOpenEye,25 and aminimum energy conformation
was calculated using CORINA. Both sets of conformations from
OMEGA were generated in chloroform (ε ¼ 4.8, Sheffield solvation
model26) to mimic the apolar portion of cell membranes. The
conformational sampling methodology and its implementation
have been described elsewhere.25,27,28 A RMSD-based clustering
procedure implemented in the Diverse Subset tool from the MOE
suite was then applied to reduce the number of conformers arising
from conformational sampling. Partial charges were calculated on
the final conformers using the PM3 semi-empirical method
implemented in Spartan (v1.1.4).29
Molecular Descriptors
A set of 293 2D and 3D-molecular descriptors30 were computed
for the conformation obtained by CORINA, and on the conformers
from conformational sampling with OMEGA. Computed descriptors
include atom and bond counts, adjacency, distance matrix de-
scriptors, Kier and Hall connectivity, kappa shape indices, phar-
macophore feature descriptors, partial charge descriptors, surface
area, volume, shape descriptors and MOE-based vsurf de-
scriptors.30,31 Some additional descriptors were also calculated. The
lipophilicity distribution coefficient (logD at pH ¼ 7.4) was
computed using the MarvinView (v18.15.0) tool. The virtual logP
arising from a molecular lipophilicity potential (logP (MLP)) was
obtained with VEGA ZZ.32,33 The three-dimensional solvent acces-
sible polar surface area (SA 3D PSA) was calculated with PyMOL
v1.7.4 as described before.16
Conformer-Dependent Descriptor Sets
Seven sets of descriptors were generated for the DOSmacrocycle
and the linear drug set. The first two were based on the 2D-struc-
ture (named “2D”) and the single minimum energy conformer from
CORINA (named “3D”). The remaining five descriptor sets were
calculated on selected conformers arising from the conformational
ensembles from OMEGA, i.e. on the minimum energy conformer
(named “MEC”), the conformer with the lowest solvent accessible
3D PSA (named “MinPSA”), the conformer having the median PSA
(named “MedPSA”), the conformer with the median radius of gy-
ration (named “MedRgyr”) and a virtual conformer based on the
median value for all descriptors (named “Median”). These were
chosen as we recently found that selection of conformations based
on their polar surface area or radius of gyration provided a better
approximation of the biologically relevant conformations than an
energy-based selection.28 The overall workflow of conformational
search and descriptor calculation is shown in Fig. 3.
Training and Test Sets
The DOS macrocycle set was divided into training and test sets
by applying a multivariate analysis based on a principal component
analysis (PCA) followed by D-optimal onion design (DOOD).34
Briefly, DOOD is a multivariate method for selecting representa-
tive compounds from a chemical space defined by the molecular
properties and is based on a score vector obtained from principal
component analysis (PCA). According to the score vector, the
dataset is split into different layers and from each onion-like layer
training compounds are chosen. In this study, the score was
calculated with SIMCA (version 10.5, Umetrics) and the D-optimal
onion design experiment was performed using the MODDE
(version 7.0, Umetrics). The list of compounds used in the training
(47) and test (23) set is provided in the Supplementary Table 1. The
Fig. 2. Distribution of (a) molecular weight (MW), (b) calculated lipophilicity (cLogP), (c and d) the number of hydrogen bond acceptors and donors (HBA and HBD), (e) the to-
pological polar surface area (TPSA), and (f) the number of rotatable bonds (NRotB) for the members of the three sets of compounds investigated. Calculated descriptors are plotted in
green for the linear drug set, in red for the DOS macrocycle set and in blue for the bRo5 drug set. Values that adhere to the Lipinski's rule of 520 and Veber's rule21 are marked with
grey shading.
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“Diverse Subset” tool provided in the MOE suite.Classification Models
Random Forest (RF) as implemented in the WEKA v3.8 data
mining tool was used for the binary classification.35 The random
forest model was built with 10 trees and 1 seed (default setting), no
additional parameters were set as tuning of other parameters did
not improve the quality of the model. Method details have been
described elsewhere.36,37 To evaluate the quality of the classifica-
tion, the Matthews Correlation Coefficient (MCC)38 was used. It
takes into account true positives and negatives and returns a valuebetween 1 and þ1. A coefficient of þ1 represents a perfect pre-
diction, 0 an average random prediction, and 1 the worst possible
prediction. In general, MCC values greater than 0.4 are considered
to be predictive,39
MCC¼ TP TN FP FNffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiðTPþ FPÞðTPþ FNÞðTNþ FPÞðTNþ FNÞp
where TP are true positives, TN are true negatives, FP are false
positives, and FN are false negatives. In addition, each class (posi-
tive or negative) is assessed with specificity (or true negative rate,
specificity ¼ TN/(TN þ FP)) and sensitivity (true positive rate,
sensitivity ¼ TP/(TP þ FN)), defined by the proportion of correctly
Fig. 3. Workflow to generate the data matrix.
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cross validation or test set validation, respectively. For each dataset,
suitable descriptors were chosen based on the automatic variable
selection procedure (CfsSubsetEval-BestFirst) as implemented in
the Weka software.35,40 CfsSubsetEval combined with the BestFirst
algorithm has been shown to be a better attribution selection
method as compared to others.37
Regression Models
Multiple linear regression (MLR) models and statistics were
obtained with QSARINS v.2.2.2 (www.qsar.it).41 To select variables,
we used the genetic algorithm (GA) tool implemented in the soft-
ware using the following parameters: descriptors limit: 5, Pop size:
50, 5000 generation/size (iteration), mutational rate 50. All models
were obtained after data normalization. For any model we provide:
correlation coefficient (R2), adjusted correlation coefficient (R2adj), s
(standard error of estimate), F (Fisher value), RMSE (root mean
square error), MAE (Mean Absolute Error), PRESS (Predictive Re-
sidual Sum of Squares) and Q2 (Explained variance in prediction,
Leave- One-Out cross validation). Definitions for each term are
described elsewhere.42,43
NMR Spectroscopy
The NMR spectra of G16 (CDCl3 and DMSO‑d6) and E2-enant
(DMSO‑d6) were recorded at 25 C on an 800 MHz BRUKER Avance
III HD NMR spectrometer equipped with a 5 mm TCI cryogenic
probe, while the spectra of E2-enant in CDCl3 and D2O were recor-
ded on a 600 MHz Bruker Avance Neo NMR spectrometer with a
5 mm TCI cryogenic probe. The assignments were deduced using
HSQC, HMBC, NOESY, TOCSY and COSY experiments. A single set of
sharp peaks was observed for both macrocycles, revealing that they
populate conformational ensembles in which individual conforma-
tions are separated by low energy barriers (<1 kJ/mol). The structure
of G16 is found in Supplementary Table 1, while E2-enant is the
enantiomer of E2 (Supplementary Table 1). E2-enant was used
because of lack of material for the four macrocycles in series E.
NOESYbuildupswere acquiredwith 7mixing times (100, 200, 300,
400, 500, 600 and 700 ms), without solvent suppression, with the
relaxation delay set to 2.5 s, and using 16 transientswith 512 and 2048
points collected for the f1 and f2 dimensions, respectively. The NOE
peak intensities were calculated according to ([cross peak1  crosspeak2]/[diagonal peak1  diagonal peak2]).0.5 For the calculation of
the initial buildup rates (sij) a minimum of 4 mixing times giving a
linear (R2  0.95) build-up were used. Interproton distances (rij) were
calculatedaccording to theequation rij¼ rref (sref/sij)(1/6)usinggeminal
methylene protons (1.78 Å) as internal distance reference.
NAMFIS Analysis
Conformation ensembles of G16 and E2-enant were generated
using the Monte Carlo conformational search algorithm with in-
termediate torsion sampling, 50 000Monte Carlo steps followed by
molecular mechanics energy minimization with Macromodel
(v12.1), with the RMSD cut-off set to 2.0 Å, as implemented in the
Schr€odinger Suite. For each energy minimization, the Polak-Ribiere
type conjugate gradient (PRCG) with a maximum of 5000 iterative
steps was used. Conformations within 42 kJ/mol from the global
minimumwere kept. Conformational searches were done using the
five force fields OPLS, OPLS-2005, OPLS3e, AMBER* andMMFF, each
with the GB/SA implicit solvation model which represent apolar
(ε ¼ 4.8) and polar (ε ¼ 80.0) environments, respectively. Subse-
quently, the ensembles from the conformational searches using
different force fields were combined, and redundant conformations
were eliminated (non-hydrogen atom RMSD cutoff set to 2.0 Å
(G16) and 1.0 Å (E2-enant)).
Solution ensembles were determined by fitting the experi-
mentally measured distances and coupling constants to those back-
calculated from computationally predicted conformations using
the NAMFIS algorithm.44,45 Distances to methylene protons were
treated according to the equation d ¼ (((d16) þ (d26))/2)1/6, and to
methyl protons according to d ¼ (((d16) þ (d26) þ (d36))/3)1/6.
The output solution ensembles were validated using standard
methods, that is through evaluation of the reliability of the
conformational restraints by the addition of 10% random noise to
the experimental data, by the systematic removal of individual
restraints, and by comparison of the experimentally observed and
back-calculated distances.45
Results and Discussion
Classification Models for Cell Permeability
Machine learning (ML) methods are finding increasing use due
to their efficiency in uncovering patterns in complex and
Fig. 4. Random-Forest classification of high and low-medium permeable compounds
for the uncharged form of the compounds in (a) the DOS macrocycle set and (c) the
linear drug set. The black bars indicate the accuracy with which the permeability of the
compounds in each of the two sets is predicted, as determined by 5-fold cross vali-
dation. The MCC value (range1 to þ1) of each model is indicated by the green circles.
(b) Plot of permeabilities for the members of the DOS macrocycle set. Macrocycles
having low-medium permeabilities are denoted with smaller, red-orange circles, those
having high permeabilities have larger, yellow-green-blue circles. The misclassified
macrocycle is indicated with an arrow.
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derstanding may be poor. We built random forest (RF)-based
classification models for the cell permeability of the DOS macro-
cycle set and used the linear drug set as a comparator set.37,46 The
threshold value for distinguishing compounds having low-medium
permeability across Caco-2 cell monolayers from those having high
permeability was set at 10  106 cm/s as this threshold has been
used in industrial drug discovery projects.4
For the DOS macrocycle set excellent permeability models were
obtained based only on 2D descriptors and their quality improved
when the macrocycles were treated as uncharged (>90% accuracy,
MCC ¼ 0.80, 5-fold CV) instead of as charged species (Fig. 4a,
Supplementary Table 4). When considering a balanced prediction
of highly permeable and low-medium permeable compounds, 2D-
descriptors for the uncharged form again performed better than
those of the charged form. The overall accuracy of high versus low-
medium permeable was found to be 94 and 87%, respectively, for
the uncharged form as compared to 73 and 33% for the charged
form. Test set prediction confirmed the statistical quality of the
model (n ¼ 23, MCC ¼ 0.73) (Supplementary Table 5). It is impor-
tant to note that the model based on 2D descriptors for the un-
charged macrocycles succeeds in the successful classification of the
stereo- and regioisomeric macrocycles in series D-G, with only one
exception (Fig. 4b). The macrocycles in these series have perme-
abilities ranging from low-medium to high, and the single mis-
classified macrocycle has a permeability very close to the threshold
value. The macrocycles in series A-C, that all have high perme-
abilities were also correctly predicted, just as all macrocycles in the
unique (U) series which have low-medium as well as high
permeabilities.
Classification models were also built using descriptors calcu-
lated from the different 3D conformations (3D, MEC, MinPSA,
MedPSA, MedGyr and Median) for uncharged and charged mac-
rocycles in the same manner as for the 2D-models (Supporting
Information, Supplementary Tables 4 and 5). Perhaps surprisingly,
the use of 3D descriptors decreased the statistical quality of the
models (Fig. 4a). Although >70% of the compounds were correctly
predicted by most models, 3D descriptor-based models suffer from
a high false-positive rate. It is possible that the poor performance of
the 3Dmodels is due to that the DOSmacrocycle set is composed of
a large number of stereo- and regioisomers and/or that the selected
conformations were not relevant for permeability. The final 2D (and
3D)models weremainly governed by lipophilicity and polar surface
area (Supplementary Table 6).
For the linear drug set17 we focused on the four descriptor sets
that provided good or acceptable models for the DOS macrocycle
set (2D, 3D, MedPSA, andMedGyr), as well as theMEC set, and built
models for the drugs in their uncharged form. In total 79 com-
pounds (55 high permeable and 24 low permeable) were used for
development of classification models. The best model was again
based on 2D descriptors, and classified more than 78% and 88% of
the drugs in the training and test sets, respectively, correctly
(MCC ¼ 0.47 and 0.69, respectively, 5-fold cross-validation) (Fig. 4c,
Supplementary Table 7). In this case, 3D-descriptor based models
performed almost as well as the model based on 2D descriptors, i.e.
with an overall accuracy of 71e76% (67e79% for the test set) and a
MCC of 0.30e0.42 (0.39e0.50 for the test set) (Supplementary
Table 7). The improved performance of the 3D models, as
compared to the DOS macrocycle set, may be due to that the linear
drug set contains fewer stereocenters and/or that conformational
sampling is more successful than for the DOS macrocycle set.
Overall, the results for these two sets of compounds suggest that
machine learning-based classification models can be used as a
virtual permeability filter to distinguish low and high permeable
compounds at the stage of design in early drug discovery projects. It
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are faster to calculate, performed better than the more time-
consuming 3D models for both sets of compounds. Interestingly,
the difference in performance between the 2D and 3D models was
greater for the DOS macrocycle set than for the linear drug set.
Potentially, this is caused by that it is more difficult to sample
biologically relevant conformational space for macrocycles than for
linear compounds.
Experimental 3D Structural Information Improves Cell Permeability
Models
We have reported that excellent models for efflux inhibited
permeability across Caco-2 cells were obtained for the bRo5 drug
set when knowledge about conformational preferences and 3D
structural information was incorporated in building of the
models.16 Thus, cell permeability was highly correlated to the
minimum solvent accessible 3D PSA (Min SA 3D PSA) calculated
from multiple crystal structures of each drug (Fig. 5a, black dots,
r2 ¼ 0.90), whereas the correlation to TPSA was poor (r2 ¼ 0.36).16
Ideally, cell permeability should be modelled prior to synthesis, but
identification of the permeating conformation(s) by conforma-
tional sampling is often non-trivial for macrocycles and drugs in
bRo5 space.28 We therefore used the bRo5 drug set to assess if
calculated conformations can be used for prediction of cell
permeability, and how accurate such models may be. The correla-
tion between cell permeability and the Min SA 3D PSA of the
conformations obtained by conformational sampling using OMEGA
was weaker than when crystal structure conformations were used
(Fig. 5a, red dots, r2 ¼ 0.52), but still stronger than the correlation
with TPSA (r2 ¼ 0.36).
Inspired by the finding that a better model for cell permeability
was obtained based on the Min SA 3D PSA of sampled conforma-
tions for the bRo5 drug set than on their TPSA, we investigated the
importance of incorporating 3D structural information in model-
ling permeability of the linear drug set. For this set 2 crystal
structures had been reported in the CSD and PDB for 12 of the drugs
(Supplementary Tables 8 and 9). Also for this set of drugs better
models for cell permeability were obtained based on the Min SA 3D
PSA of the experimentally determined conformations (r2¼ 0.53), or
sampled conformations (r2 ¼ 0.43), than when TPSA was used
(r2 ¼ 0.10) (Fig. 5b and Supplementary Fig. 2). However, the qualityFig. 5. Correlation between efflux inhibited cell permeability across Caco-2 cell monolaye
calculated for (a) ten compounds from the bRo5 drug dataset16 and (b) twelve compounds fro
crystal structures deposited in the PDB or CSD that differed by an RMSD 0.75 Å. Min SA 3D
in black, while the correlations in red are the Min SA 3D PSA conformations calculated byof the model based on experimentally determined conformations is
significantly lower than that of the bRo5 drug set.
Regression Models of Cell Permeability for the DOS Macrocycle Set
Since accurate predictions of permeability are desired in the
lead optimization process, QSPR strategies were applied to the DOS
macrocycle set. Most compounds in this set belong to series of
stereo- and regioisomers and it is therefore attractive in efforts to
unravel how incorporation of 3D structural information impacts
cell permeability modelling. We investigated both whether global
regression models of cell permeability could be determined for this
compound set, as well as if models for individual series could be
obtained.
Global Models
Since polarity and lipophilicity have been shown to be strongly
correlated to permeability,4 a relationship between permeability
and calculated polar surface area or lipophilicity was first looked for
(Supplementary Table 10). However, no significant correlations
were found for the neutral form of the macrocycles independent of
if 2D or 3D versions of the two descriptors were used (r2 ¼ 0.04;
0.03). Then MLR models for cell permeability were built using
QSARINS for the seven sets of descriptors described in theMaterials
and Methods section, i.e. 2D, 3D, MEC, MinPSA, MedPSA, MedGyr
and Median. The best model was obtained for the uncharged form
of the macrocycles using the Median set, but the test set validation
failed (RMSE ¼ 0.35). The other six models were of slightly lower
quality, and attempts to build models for the charged forms of the
macrocycles did not provide any improvement (Supplementary
Table 11).
Modelling Series
The difficulties to obtain a global permeability model for the
entire DOS macrocycle set could e.g. originate from that flexibility
and/or protonation state varies between the series. To investigate
the influence of variation between series correlations between cell
permeability and polar surface area or lipophilicity were investi-
gated for the uncharged form of the compounds in the seven series
of macrocycles (A-G, cf. structures in Fig. 1). Strong correlations
(r2 > 0.7), having the expected negative slope, were found between
the cell permeability of the four macrocycles of series E and the SArs [log (Papp AB-Inh)] and the minimum solvent accessible 3D PSA (Min SA 3D PSA)
m the linear drug dataset. The compounds included in the correlations had at least two
PSAs were calculated from the crystal structures of the compounds for the correlations
OMEGA.
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(Fig. 6). In addition, permeability correlated positively with the
calculated LogP(o/w) and the LogP (MLP) of the MedGyr conforma-
tion for this series. No, or poor, correlations were found for the
other six series (Supplementary Table 10), with difficulties being
particularly evident for series G (Fig. 6).Fig. 6. Correlations between the cell permeability of the compounds in series E (left panels)
MinPSA and MedPSA conformations of these macrocycle (rows 1e3). The correlation betw
(bottom row). Examples of structures from each series are shown at the top.NMR Derived Solution Ensembles of DOS Macrocycles
Based on the above analysis of the individual stereo- and regio-
someric series in the DOS macrocycle set we hypothesized that the
difficulties in modelling their cell permeability originated from that
the flexibility of these series prevents the prediction of the relevantand G (right panels) of the DOS macrocycle set and SA 3D PSA calculated for the MEC,
een permeability and the lipophilicity (log P (MLP)) for the two series is also shown
Table 1
Conformational Ensembles of Macrocycles E2-enant and G16 in Apolar and Polar Solutions as Determined by NAMFIS Analysis.a
.
Cpd CDCl3 DMSO‑d6 D2O
Conf. No Molar Fraction (%)b Conf. No Molar Fraction (%)b Conf. No Molar Fraction (%)b
E2-enant 1 4 1 6 3 81
2 11 2 3 7 2
3 81 3 76 8 3
4 3 5 11 9 4
6 4 10 7
11 3
G16 1 3 3 22
2 11 6 3
3 34 7 6
4 49 8 4







a Conformations populated in more than one solvent are marked with italics and bolded values.
b Population in % of the indicated solution conformer. Conformers having populations 1% have been discarded.
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series E and G, i.e. the series displaying the best and worst correla-
tions to permeability (Fig. 6), suggest that series G is much more
flexible because of its three side chains and probably also due to a
more flexible macrocyclic ring. The difference in flexibility is sup-
ported both by the number of rotatable bonds (NRotB) and by the
Kier flexibility index47 (F) of the macrocycles in these two series
(Supplementary Fig. 3). To get experimental insight into the flexi-
bility of the macrocycles in series E and G, we determined the so-
lution conformational ensembles for one macrocycle from each
series, E2-enant and G16 (Table 1, Supplementary Table 1), by
deconvolution of time-averaged NMR data using the NAMFIS algo-
rithm (cf. Supplementary Tables 12-18 for E2-enant and
Supplementary Tables 19-24 for G16).44 The enantiomer of macro-
cycle E2 was used as insufficient amounts of material was available
for the four compounds in series E. The NAMFIS method was chosen
as it has previously been successfully applied for the description of
the solution ensembles of diverse sets of macrocyles,48e50 some of
them similar to G16 and E2-enant in size and flexibility. As the
conformations responsible for cell permeability are expected to be
found among those in the solution ensembles,48 the solution en-
sembles of E2-enant and G16 were then compared to the sampled
ensembles used for prediction of cell permeability.
Description of Solution Ensembles
Macrocycle E2-enant from series E populated from four to six
conformations in the increasingly polar solvents CDCl3, DMSO‑d6
and D2O (Table 1). Chloroform (ε ¼ 4.8) was used to mimic the cell
membrane (ε ¼ 3.0),4 while DMSO and water mimicked the plasma
and cytosol. Conformation number 3 is the major one and repre-
sents approximately 80% of the ensemble in each solvent, while
each of the minor ones represent 11% of the ensembles. The
pairwise RMSD values between the most different conformationsranged from 2.5 to 3.2 Å in the three solvents (Supplementary
Table 25), confirming a low flexibility for E2-enant. In contrast,
macrocycle G16 from series G is more flexible. In DMSO‑d6 G16
populates two major (number 3 and 10) and nine minor confor-
mations, with a pairwise RMSD value of 5.26 Å between the most
different conformations (Supplementary Table 26). G16 populates
two major (number 3 and 4) and three minor conformations in
CDCl3, and the RMSD value between the most different confor-
mations was 4.95 Å. G16 had a too low solubility to allow deter-
mination of its solution ensemble in D2O.
Structural Comparison of Solution and Sampled Ensembles
The experimentally determined solution ensembles for E2-
enant and G16 were compared to ensembles obtained by confor-
mational sampling using OMEGA within a 25 kcal/mol energy
window in polar (ε ¼ 80) and apolar (ε ¼ 4.8) implicit solvents
(Fig. 7). For E2-enant the predictedminimum energy conformation
(MEC) in each of the two implicit solvents was similar (RMSD
2 Å)28,51 to the experimentally determined conformations in
CDCl3 and DMSO‑d6, respectively (Fig. 7a), indicating that OMEGA
predicts relevant solution conformers for this macrocycle. An
increasing number of conformations sampled at higher energies
were also similar to the conformations in the experimental en-
sembles. For the more flexible G16 only one of the minor confor-
mations in the DMSO ensemble (number 12, 6%) was similar to the
predicted MEC in an implicit polar solvent (RMSD 2 Å, Fig. 7b). In
CDCl3 a predicted conformation similar to minor conformation 2
(11%) was found 1 kcal/mol above the MEC. Predicted conforma-
tions similar to the other solution conformations of G16were found
only at energies 5 kcal/mol above the MEC, revealing the diffi-
culties in predicting conformations for this flexible macrocycle. In
fact, conformation 4 in CDCl3 and 3 in DMSO, i.e. one of the two
major conformations in each solution, was sampled only at
Fig. 7. Enrichment of solution conformations of E2-enant (a) and G16 (b and c) in CDCl3 and DMSO‑d6 in conformational ensembles generated with OMEGA in apolar (ε ¼ 4.8, top
panels) and polar (ε ¼ 80, bottom panels) implicit solvents. For G16 panel b refers to the overall macrocycle, while panel c refers to the macrocycle core, defined as the heavy atoms
in the macocycle ring and the first attached heavy atom of the substituents. An RMSD value of 2.0 Å was used as a cut-off for similarity. The numbers of the experimental
conformations are indicated on the right Y-axis.
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core of G16 was predicted better by conformational sampling; the
MECs resembled the cores in all conformations but that of number
3 in CDCl3 (Fig. 7c, Supplementary Table 27). This highlights that
the cores are more rigid, and that the side-chains of G16 are the
main sources of flexibility and thereby of the difficulties to sample
the biologically relevant conformations.
Polar Surface Area of Solution and Sampled Ensembles
The solvent accessible 3D polar surface area (SA 3D PDA) is a key
determinant of cell permeability.16 It showed only a small variation
between the solution conformations of the rigid E2-enant (<25 Å2
between conformations, Fig. 8a). PSA differences were also small
between the ensembles sampled with OMEGA in apolar and polar
environments. In addition, the SA 3D PSA of the sampled and so-
lution ensembles overlapped well; in agreement with that SA 3D
PSA could be used to develop good models for the permeability of
series E. The SA 3D PSA of the flexible G16 showed a significantly
larger variation between conformations, reaching a difference of
>70 Å2. As for E2-enant the SA 3D PSA of the sampled ensembles
differed little between an apolar and polar environment. However,
for G16 the SA 3D PSA of the second most populated conformation
in each solution ensemble was far outside of 25e75 percentiles and
close to the minimum of the sampled ensembles. This illustrates
the difficulties of conformational sampling in reproducing the
properties of the solution ensembles of flexible compounds such as
those in series G of the DOS macrocycle set.Overall the NMR studies confirm that the macrocycles in series E
are significantly less flexible than those of series G. The study also
supports that the biologically relevant conformations are better
reproduced by conformational sampling for the rigid macrocycles
than for the more flexible ones. We therefore conclude that the
difficulties in modelling the permeability for the DOS macrocycle
set, and all but one of its series, originate from the failure of
conformational sampling to identify their biologically relevant
conformations.Regression Models of Cell Permeability for the Linear Drug Set
We investigated if flexibility is a limiting factor for modelling of
permeability also for non-macrocyclic compounds using the linear
drug set. To this aim, the compounds were split in two classes
according to the their flexibility as estimated by the number of
rotatable bonds, i.e. one class that had NRotB <6 and one with
NRotB 6. Then, QSPR models were built for the neutral forms of
each class as described for the DOS macrocycles. Models built
using only 2D descriptors were slightly better than models that
also used 3D structural information; in particular in prediction of
the permeability for the external test sets (Supplementary
Table 28 and Supplementary Fig. 4). As expected, the more rigid
compounds in the NRotB <6 class were slightly better modelled
than the more flexible ones in the NRotB 6 class both for the 2D
and 3D models.
Fig. 8. Solvent accessible 3D polar surface area (SA 3D PSA) for E2-enant (a) and G16 (b). The descriptor has been calculated for the conformations adopted in apolar (CDCl3) and
polar (DMSO‑d6) solutions, as determined by NMR spectroscopy, and for the conformations generated with OMEGA in apolar (ε ¼ 4.8) and polar (ε¼ 80) implicit solvents. The size of
each circle is representative of the population (in %) of each of the experimentally determined conformations. Boxplots show minimum and maximum values as whiskers, 25th and
75th percentiles as boxes, 50th percentiles as horizontal black bars. The MEC is indicated with a red star for each of the conformational ensembles generated with OMEGA, and the
number of conformations (n) is given above each boxplot.
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We found that machine learning-based classification models can
be used to distinguish between low-medium and highly permeable
compounds, both for the DOSmacrocycle set and the linear drug set.
Models based on 2D descriptors, which are fast to calculate, out-
performed those based on more time-consuming sampling of 3D
conformations. We conclude that 2D-based classificationmodels are
precise enough for use as virtual filters in early phases of drug dis-
covery projects, when prioritizing compounds for synthesis from
larger sets in similar chemical space. Importantly, the 2D machine
learning-based models succeeded in the correct permeability clas-
sification of regio- and stereoisomeric macrocycles.
In the lead optimization phase better predictions of cell
permeability are desired than a classification into low-medium or
high. Earlier we have reported that the minimum solvent accessible
3D PSA of conformations determined by X-ray crystallography
provided a more accurate model for cell permeability than the 2D
descriptor TPSA for the 11 drugs in the bRo5 drug set.16 Herein, we
found this to be true also for a subset of the linear drug set. We also
found that use of the conformations having the minimum solvent
accessible 3D PSA4,16 from conformational sampling provided
reasonable permeability models both for the bRo5 drug set and for
the subset of the linear drug set, supporting that 3D descriptors
should be useful. Consequently, we tried to shed light on twomajor
questions regarding regression permeability models for macro-
cycles, i.e. i) do 3D descriptors calculated from conformers providebetter models than those based only on 2D descriptors, and ii) for
which macrocycles can relevant conformations be predicted by
conformational sampling? Unfortunately, global QSPR models
based on 3D descriptors could not be developed for the 70 com-
pounds in the DOS macrocycle set. However, a strong correlation
between permeability and solvent accessible 3D PSA was found for
one of the stereo- and regioisomeric series of this set.
Determination of the conformations populated in apolar and
polar environments by NMR spectroscopy for a macrocycle from
the well predicted series and one from a series which failed to give
any permeability model confirmed that the well predicted series
was more rigid. For the macrocycle from the well predicted, rigid
series the sampled minimum energy conformations resembled the
conformations in the solution phase ensembles (RMSD <2 Å). In
contrast, conformations similar to those of the solution ensembles
of the flexible series were usually found at energies significantly
above the global minimum, i.e. at 5e15 kcal/mol above the mini-
mum. It therefore appears that for flexible macrocycles, confor-
mational sampling fails to identify the conformations that are
essential for permeability. This arises from the inability of the force
field to identify these conformations, but is not a result of incom-
plete sampling of relevant conformational space. This conclusion is
in line with that from a recent study of ten drugs in bRo5 space.28
The well predicted series in the DOS macrocycle set has a Kier
flexibility index of 9.3. Interestingly, the Kier flexibility indexes of
the compounds in the linear drug set that were fairly well predicted
based on the minimum energy conformations range up to 10. We
V. Poongavanam et al. / Journal of Pharmaceutical Sciences 110 (2021) 301-313312therefore speculate that a Kier flexibility index of approximately 10
constitutes a current upper limit for reasonably accurate confor-
mational analysis using molecular mechanics forcefields for
ranking of conformations. In an earlier study we reported that
manual scoring of the overall polarity, intramolecular hydrogen
bonding and steric shielding of polar groups in the low-energy
conformations allowed ranking of the permeability of some of the
more flexible series in the DOS macrocycle set.15 These more flex-
ible series are expected to behave as molecular chameleons that
adapt their conformations to the environment in a manner which
results in dynamic exposure of polar surface area, allowing com-
pounds to display both high cell permeability and aqueous solu-
bility.15,16,52 The challenges posed by modelling of permeability for
molecular chameleons also apply to flexible cyclic peptides, as re-
ported previously by others.10,14 We conclude that regression
modelling of macrocycle cell permeability requires an analysis of
the investigated dataset in terms of flexibility and its impact on the
formation of intramolecular hydrogen bonds and other structural
features masking polar regions, rather than a fast but a critical
submission to computational tools.Acknowledgements
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